07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
The first half of 2020 has presented governments, business and individuals with an unprecedented set...
Read More >
In the recent decision Newton v. Morgantown Machine & Hydraulics, the Supreme Court of Appeals of We...
Read More >
In this episode of the FCPA Compliance Report, I visit Michael DeBernardis, Counsel at Hughes Hubbar...
Read More >
On August 8, 2019, the Department of Labor (DOL) released an Opinion Letter clarifying that parents ...
Read More >
Control Testing – Has the company reviewed and audited its compliance program in the area relating ...
Read More >
On November 1, 2017, the Ohio Board of Building Standards (OBBS) adopted an update to the Ohio Build...
Read More >